Cardiac amyloidosis nuclear cardiac scans
|
Cardiac amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac amyloidosis nuclear cardiac scans On the Web |
|
American Roentgen Ray Society Images of Cardiac amyloidosis nuclear cardiac scans |
|
Risk calculators and risk factors for Cardiac amyloidosis nuclear cardiac scans |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]; Aarti Narayan, M.B.B.S [3]
Overview
Nuclear cardiac scans like MUGA and radionuclide ventriculography (RNV) are not used routinely early in the diagnosis of cardiac amyloidosis. However, when performed, these scans show increased uptake of technetium by the myocardium correlating well with the degree of involvement.
Nuclear Cardiac Scans
99mTechnetium-dicarboxypropane diphosphonate (99mTc-DPD) is an isotope available in Europe. Imaging with 99mTc-DPD is shown to help distinguish between AL and ATTR cardiac amyloidosis. [1]
References
- ↑ Perugini E, Guidalotti PL, Salvi F; et al. (2005). "Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy". Journal of the American College of Cardiology. 46 (6): 1076–84. doi:10.1016/j.jacc.2005.05.073. PMID 16168294. Unknown parameter
|month=ignored (help)